Overview
Advances in Neurostimulation for Managing Chronic Post Amputation Pain
Click the "Start Activity" button to indicate you have reviewed the CME/CE information for this activity.
Start Activity
Everything about chronic post-amputation pain (CPAP) is complex: from its disparate pathophysiological mechanisms to complex treatment approaches. Join leading pain management expert, Leonardo Kapural, MD, PhD, and vascular surgeon, Billy Kim, MD, FACS, as they discuss the management of CPAP complexities and insufficiencies of the current therapeutic landscape, as well as emerging evidence on novel devices in this series of videos.
• Describe the burden and mechanisms of post amputation pain
• Assess the efficacy and risks associated with current pharmacologic approaches to the treatment of post amputation pain
• Evaluate the role of neuromodulation techniques in the treatment of post amputation pain
• Review the most recent evidence and ongoing trials on investigational devices employing 10 kilohertz electrical nerve block for postamputation pain
Carolinas Pain Institute
Professor of Anesthesiology, Florida Atlantic University
Director-At-Large International Neuromodulation Society
Director-At-Large North American Neuromodulation Society
Charlotte, NC
The Academy for Continued Healthcare Learning (ACHL) requires that the faculty participating in an accredited continuing education activity disclose all affiliations or other financial relationships within 24 months (1) with the manufacturers of any commercial product(s) and/or provider(s) of commercial services discussed in an educational presentation and (2) with all ineligible companies. All relevant financial relationships have been mitigated prior to this activity.
The following financial relationships have been provided:
Leonardo Kapural, MD, PhD (Faculty)Advisory Board: Avanos, Biotronik, Neuralace, Neuros, PresidioResearch: Biotrinik, FUS, Gimer, Man and Science, Medtronic, Neuralace, Neuros, Nevro, Saluda, SAOL Therapeutics, Sollis, XaludSpeakers Bureau: Avanos, Nevro, Saluda
Billy Kim, MD, FACS (Faculty)No financial relationships to disclose
Discussion of Off-Label, Investigational, or Experimental Drug/Device Use: Anti-inflammatories, anticonvulsants, antidepressants, opioids, and investigational neuromodulation techniques not labeled or approved for post amputation pain.
For questions, contact Laurie Novoryta at Lnovoryta@achlcme.org.
The Academy for Continued Healthcare Learning is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The Academy for Continued Healthcare Learning designates this enduring material for a maximum of .75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
